<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33397838</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2329-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><PubDate><Year>2021</Year><Month>Jan</Month><Day>05</Day></PubDate></JournalIssue><Title>Annals of transplantation</Title><ISOAbbreviation>Ann Transplant</ISOAbbreviation></Journal><ArticleTitle>Transplantation of Enterovirus 71 Virion Protein Particle Vaccine Protects Against Enterovirus 71 Infection in a Neonatal Mouse Model.</ArticleTitle><Pagination><StartPage>e924461</StartPage><MedlinePgn>e924461</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12659/AOT.924461</ELocationID><Abstract><AbstractText>BACKGROUND Enterovirus 71 (EV71) is the pathogen most likely to cause HFMD in young children (1-5 years old). A small number of virion protein (VP) vaccine candidates are considered as the protective molecules in EV71 models. This study aimed to observe comprehensive immunogenicity for a promising EV71 vaccine depending on VP1 in neonatal mouse EV71 models. MATERIAL AND METHODS VP1 was isolated from patients and associated peptides were synthesized. EV71 particles were inactivated and mixed with Freund's complete adjuvant to prepare peptide vaccines. An EV71 vaccine was administered to establish the mouse model and the mice were infected with EV71. Hematoxylin and eosin staining was used to examine inflammatory response in EV71-infected neonatal mice. A semi-quantitative reverse transcription-polymerase chain reaction assay was performed to evaluate the levels of EV71 virus in skeletal muscle, small intestines, and brain tissues. RESULTS Three peptides were selected from 20 VP1 peptides due to their exhibition of the highest immunogenicity. The peptide injection improved inflammation and decreased EV71 particle levels in muscle, small intestines, and brain tissues. The injection also decreased lesions in the small intestines of EV71-infected mice and protected brain tissues from the EV71 infection. CONCLUSIONS The present study confirmed the immuno-protective effects of VP1 vaccine transplantation in mice infected with EV71 virus. Our results provide valuable information that can be used in further studies investigating the specific mechanism of the anti-EV71 vaccine.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The Third Affiliated Hospital of Zunyi Medical University/The First People's Hospital of Zunyi, Zunyi, Guizhou, China (mainland).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of Zunyi Medical University, Zunyi, Guizhou, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>The Third Affiliated Hospital of Zunyi Medical University/The First People's Hospital of Zunyi, Zunyi, Guizhou, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Shuhong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Graduate School of Zunyi Medical University, Zunyi, Guizhou, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Mingyang</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Graduate School of Zunyi Medical University, Zunyi, Guizhou, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Xinghui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Third Affiliated Hospital of Zunyi Medical University/The First People's Hospital of Zunyi, Zunyi, Guizhou, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bi</LastName><ForeName>Yunxia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Third Affiliated Hospital of Zunyi Medical University/The First People's Hospital of Zunyi, Zunyi, Guizhou, China (mainland).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>The Third Affiliated Hospital of Zunyi Medical University/The First People's Hospital of Zunyi, Zunyi, Guizhou, China (mainland).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Transplant</MedlineTA><NlmUniqueID>9802544</NlmUniqueID><ISSNLinking>1425-9524</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058425">Vaccines, Virus-Like Particle</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058425" MajorTopicYN="N">Vaccines, Virus-Like Particle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="Y">Viral Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014771" MajorTopicYN="N">Virion</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of interests</b>. None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33397838</ArticleId><ArticleId IdType="pmc">PMC7796071</ArticleId><ArticleId IdType="doi">10.12659/AOT.924461</ArticleId><ArticleId IdType="pii">924461</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen S, Yi K, Chen X, et al. A simple scoring system for quick, accurate, and reliable early diagnosis of hand, foot, and mouth disease. Med Sci Monit. 2018;24:8627&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6282650</ArticleId><ArticleId IdType="pubmed">30487478</ArticleId></ArticleIdList></Reference><Reference><Citation>Geoghegan JL, Tan le V, Kuhnert D, et al. Phylodynamics of enterovirus A71-associated hand, foot, and mouth disease in Viet Nam. J Virol. 2015;89:8871&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4524079</ArticleId><ArticleId IdType="pubmed">26085170</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zou G, Xia A, et al. Enterovirus 71 infection in children with hand, foot, and mouth disease in Shanghai, China: Epidemiology, clinical feature and diagnosis. Virol J. 2015;12:83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4464242</ArticleId><ArticleId IdType="pubmed">26036928</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Huang B, She C, et al. An epidemic analysis of hand, foot, and mouth disease in Zunyi, China between 2012 and 2014. Saudi Med J. 2015;36:593&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4436757</ArticleId><ArticleId IdType="pubmed">25935181</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong SS, Yip CC, Lau SK, Yuen KY. Human enterovirus 71 and hand, foot and mouth disease. Epidemiol Infect. 2010;138:1071&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">20056019</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KP, Goh KT, Chong CY, et al. Epidemichand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis. 2003;9:78&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2873753</ArticleId><ArticleId IdType="pubmed">12533285</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterback R, Vuorinen T, Linna M, et al. Coxsackievirus A6 and hand, foot, and mouth disease, Finland. EmergInfect Dis. 2009;15:1485&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2819858</ArticleId><ArticleId IdType="pubmed">19788821</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng M, El Khatib NF, Tu S, et al. Seroepidemiology of Enterovirus 71 infection prior to the 2011 season in children in Shanghai. J Clin Virol. 2012;53:285&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">22265829</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NT, Pham HV, Hoang CQ, et al. Epidemiological and clinical characteristics of children who died from hand, foot and mouthdisease in Vietnam, 2011. BMC Infect Dis. 2014;14:341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4068316</ArticleId><ArticleId IdType="pubmed">24942066</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Yeo A, Phoon MC, et al. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: The role of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis. 2010;14:e1076&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">20952237</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiyoshi K, Suga T, Mori A. Enteroviruses in patients experiencing multiple episodes of hand, foot, and mouth disease in the same season in Kobe, Japan, 2011. Jpn J Infect Dis. 2012;65:459&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">22996228</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SJ, Kim JH, Kang JH, et al. Risk factors for neurologic complications of hand, foot and mouth disease in the Republic of Korea, 2009. J Korean Med Sci. 2013;28:120&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3546090</ArticleId><ArticleId IdType="pubmed">23341722</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, Lu J, Kung HF, et al. The virology and developments toward control of human enterovirus 71. Crit Rev Microbiol. 2011;37:313&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">21651436</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CW, Liu CC, Lu TC, et al. Immunogenicity studies of bivalentin activated virions of EV71/CVA16 formulated with submicron emulsion systems. Biomed Res Int. 2014;2014 670506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4071850</ArticleId><ArticleId IdType="pubmed">25006583</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong P, Hsieh SY, Liu CC, et al. Production of EV71 vaccine candidates. Hum Vaccin Immunother. 2012;8:1775&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3656065</ArticleId><ArticleId IdType="pubmed">22992566</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YL, Yu CI, Hu YC, et al. Enterovirustype 71 neutralizing antibodies in the serum of macaquemon keys immunized with EV71 virus-likeparticles. Vaccine. 2012;30:1305&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">22214888</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart M, Bhatia Y, Athmaran TN, et al. Validation of a novel approach for the rapid production of immunogenic virus-like particles for blue tongue virus. Vaccine. 2010;28:3047&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">19887134</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao L, Mao F, Pang Z, et al. Protective effect of enterovirus71 (EV71) virus like particle vaccine against lethal EV71 infection in a neonatal mouse model. Mol Med Rep. 2015;12:2473&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4464482</ArticleId><ArticleId IdType="pubmed">25936344</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Wang L, Liao Y, et al. Similar protective immunity induced by an inactivated enterovirus 71 (EV71) vaccine in neonatal rhesus macaques and children. Vaccine. 2015;33:6290&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">26419198</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y, Ku Z, Liu Q, et al. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses. Vaccine. 2014;32:2406&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">24657161</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku Z, Ye X, Huang X, et al. Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps. PLoS One. 2013;8:e57601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3579802</ArticleId><ArticleId IdType="pubmed">23451250</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Huang W, Nie J, et al. A novel high-throughput vaccinia virus neutralization assay and pre-existing immunity in populations from different geographic regions in China. PLoS One. 2012;7:e33392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3306400</ArticleId><ArticleId IdType="pubmed">22438922</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin YY, Lu J, Li JL, et al. [Establishment of enterovirus 71-infected ICR neonatal mice model]. J Jiangsu Univ (Med Ed) 2017;27:385&#x2013;340. [in Chinese]</Citation></Reference><Reference><Citation>Chen Z, Lu S, Xu M, et al. Role of miR-24, furin, and transforming growth factor-beta1 signal pathway in fibrosis after cardiac infarction. Med Sci Monit. 2017;23:65&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5234678</ArticleId><ArticleId IdType="pubmed">28055991</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Duo J, Liu J, et al. A mouse muscle-adapted enterovirus 71 strain with increased virulence in mice. Microbes Infect. 2011;13:862&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">21612764</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong WX, Yan B, Yeo H, et al. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J Virol. 2012;86:2121&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302383</ArticleId><ArticleId IdType="pubmed">22130542</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Chou CT, Lei HY, et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol. 2004;78:7916&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng T, Kolpe AB, Kiener TK, et al. Display of VP1 on the surface of baculo virus and its immunogenicity against heterologous human enterovirus 71 strains in mice. PLoS One. 2011;6:e21757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128602</ArticleId><ArticleId IdType="pubmed">21747954</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo DG, Alonso S, Chow VT, et al. Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes Infect. 2007;9:1299&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">17890123</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YI, Song JH, Kwon BE, et al. Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection. Vaccine. 2015;33:6604&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">26529069</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Hsiung CA, Lu CY, et al. Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatr Res. 2006;60:466&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7086547</ArticleId><ArticleId IdType="pubmed">16940249</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan FS, Huang C, Compans RW, et al. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol. 2007;81:3514&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1866067</ArticleId><ArticleId IdType="pubmed">17251294</ArticleId></ArticleIdList></Reference><Reference><Citation>Emeny RT, Wheeler CM, Jansen KU, et al. Priming of human papillomaviru stype 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine. J Virol. 2002;76:7832&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC136358</ArticleId><ArticleId IdType="pubmed">12097595</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiu JH, Zhu H, Xu YF, et al. Necrotizing myositis causes restrictive hypoventilation in a mouse model for human enterovirus 71 infection. Virol J. 2013;10:215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3710232</ArticleId><ArticleId IdType="pubmed">23809248</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>